In the medulloblastoma, we observed 45 tumor‐specific pathogenic variants in 35 CNS tumor‐related genes, including PTCH1, PTCH2, and SMO, which are frequently altered in medulloblastomas (Table 1). The gene discussed is SMO; the disease is medulloblastoma.